Nearly all our medical research is wrong
What do we know about the state of life sciences and medical research? It’s a $200B market, takes an entire decade to bring a new medicine to market, and has a serious issue of lack of reproducibility (like when a biotech giant found only 11% of 53 landmark cancer studies could be confirmed.)
That's why we're thrilled to back Misfit and AgaMatrix co-founder Sridhar Iyengar's latest endeavor, Elemental Machines, which announced their $2.5M round and suite of connected lab products to better track scientific experiments—already cutting research time by 6+ months for some customers.
Study: Doctors’ Texts Can Prod Patients To Take Drugs, But Questions Linger
Tweet | Kaiser Health News
ACA Enrollment Pleases HHS. Insurers Will Be Tougher Crowd
Tweet | Modern Healthcare
Rock Health in the News
Hospital’s Mobile Health Project Finds Value In Fitbit Data
Tweet | mHealthIntelligence
|Pear Therapeutics||$20M||5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Bridge Builders Collaborative||MedCity News|
|Elemental Machines||$2.5M||Founders Fund, Max Levchin, Project 11 Ventures, 2M Companies, Rock Health||TechCrunch|
Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.